FTREHIGH SIGNALFINANCIAL10-K

FTRE experienced severe financial deterioration with operating losses expanding 439% to -$872.6M and net losses doubling to -$986.2M, while stockholders' equity collapsed 58.6%.

The dramatic expansion in losses coupled with the massive increase in interest expense from $200K to $69.8M suggests significant debt restructuring or refinancing under distressed conditions. The 58.6% decline in stockholders' equity indicates substantial value destruction and potential covenant violations or dilutive financing.

Comparing 2026-02-26 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

FTRE's financial position deteriorated severely across all key metrics, with operating losses expanding from -$161.9M to -$872.6M and net losses doubling to -$986.2M despite a reduction in SG&A expenses. The balance sheet shows significant stress with stockholders' equity falling 58.6% to $563.5M and total assets declining 24.1%, while interest expense exploded from $200K to $69.8M indicating major debt restructuring. Operating cash flow also declined 56.8% to $113.5M, suggesting the company is burning through cash while facing mounting losses and what appears to be a distressed financing situation.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+34800%
$200K$69.8M

Interest expense surged 34800% — significant debt increase or rising rates materially impacting earnings.

Operating Income
P&L
-439%
-$161.9M-$872.6M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-200.2%
-$328.5M-$986.2M

Net income declined 200.2% — review whether driven by operations, interest costs, or non-recurring items.

Stockholders Equity
Balance Sheet
-58.6%
$1.4B$563.5M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Operating Cash Flow
Cash Flow
-56.8%
$262.8M$113.5M

Operating cash flow fell 56.8% — earnings quality concerns; investigate working capital changes and non-cash items.

Cash & Equivalents
Balance Sheet
+47.3%
$118.5M$174.6M

Cash position surged 47.3% — strong cash generation or capital raise providing significant financial cushion.

Total Assets
Balance Sheet
-24.1%
$3.6B$2.7B

Total assets contracted 24.1% — asset sales, write-downs, or balance sheet optimization underway.

SG&A Expense
P&L
-18.6%
$560.7M$456.4M

SG&A reduced 18.6% — improved cost efficiency or headcount reduction improving operating margins.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-03-03
ADDED
Management's Discussion and Analysis of Financial Condition and Results of Operations 56 Item 7A.
Our team of approximately 14,300 employees is able to conduct operations in approximately 100 countries.
Our solutions include our clinical research units ( CRUs ) and external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics ( PK ), modeling and simulation, and biometrics.
A global bedside data capture system has been implemented across all CRUs, enabling increased efficiency and quality, and providing real time access to data.
Our service offerings are supported by technological innovations, leveraging strategic relationships with leading technology vendors together with Fortrea s operational expertise to support more connected patient and site centric solutions, digital health and decentralized clinical trial capabilities.
+7 more — sign up free →
REMOVED
Management's Discussion and Analysis of Financial Condition and Results of Operations 54 Item 7A.
Our team of approximately 15,500 employees provides services in approximately 100 countries.
Our solutions include our clinical pharmacology units and external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics ( PK ), modeling and simulation, and biometrics.
Fortrea s clinical research units ( CRUs ) are located in Leeds, U.K.
A global bedside data capture system has been implemented across all CRUs.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →